MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 532645 | Name: SB 204741
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SB-204741 is an antagonist of the serotonin (5-HT) receptor subtype 5-HT2B. It inhibits 5-HT-induced contraction of isolated rat stomach fundus, a tissue that endogenously expresses high levels of 5-HT2B receptors (pA2 = 7.95). SB-204741 is selective for 5-HT2B receptors over 5-HT1A, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2C, 5-HT3, 5-HT4, dopamine D1-3, histamine H1, α1- and α2-adrenergic, and GABAA receptors (Kis = 1-100 µM). In vivo, SB-204741 (1 mg/kg per day) prevents the development of pulmonary arterial hypertension (PAH) and reduces vascular stiffness in a Bmpr2 mutant mouse model of hereditary PAH. It also reduces blood pressure in DOCA-salt hypertensive rats.

Chemical Structure

SB 204741
SB 204741
CAS#152239-46-8

Theoretical Analysis

MedKoo Cat#: 532645

Name: SB 204741

CAS#: 152239-46-8

Chemical Formula: C14H14N4OS

Exact Mass: 286.0888

Molecular Weight: 286.35

Elemental Analysis: C, 58.72; H, 4.93; N, 19.57; O, 5.59; S, 11.20

Price and Availability

Size Price Availability Quantity
10mg USD 450.00 2 Weeks
50mg USD 1,250.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
SB 204741; SB204741; SB-204741;
IUPAC/Chemical Name
1-(1-methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea
InChi Key
USFUFHFQWXDVMH-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H14N4OS/c1-9-7-13(20-17-9)16-14(19)15-11-3-4-12-10(8-11)5-6-18(12)2/h3-8H,1-2H3,(H2,15,16,19)
SMILES Code
O=C(NC1=CC(C)=NS1)NC2=CC3=C(N(C)C=C3)C=C2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Product Data
Instruction
View handling instruction
Biological target:
SB 204741 is a selective and high affinity 5-HT2B antagonist with a pKi value of 7.1.
In vitro activity:
SB 204741 effectively counteracted the enhanced tension development in the umbilical artery of preeclamptic pregnancies, contributing to its potential role in regulating vascular responses. Reference: Eur J Pharmacol. 2009 Mar 1;605(1-3):129-37. https://pubmed.ncbi.nlm.nih.gov/19248248/
In vivo activity:
SB 204741 has potential in mitigating myocardial damage through multifaceted mechanisms. In a rat model of isoproterenol-induced myocardial remodeling, SB 204741 improved hemodynamic and ventricular functions. There were reductions in the expression of proteins associated with inflammation, stress kinases, and apoptotic factors, along with an increase in proteins related to heat shock response, autophagy, and cell survival. Reference: Apoptosis. 2015 Apr;20(4):455-65. https://pubmed.ncbi.nlm.nih.gov/25544272/
Solvent mg/mL mM
Solubility
DMSO 100.0 349.22
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 286.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Seto SW, Lam HY, Lau WS, Au AL, Lam TY, Chim SS, Ngai SM, Chan SW, Leung TY, Yeung JH, Kong SK, Leung GP, Lee SM, Kwan YW. Role of monoamine oxidases in the exaggerated 5-hydroxytryptamine-induced tension development of human isolated preeclamptic umbilical artery. Eur J Pharmacol. 2009 Mar 1;605(1-3):129-37. doi: 10.1016/j.ejphar.2008.12.054. PMID: 19248248. 2. Bharti S, Rani N, Bhatia J, Arya DS. 5-HT2B receptor blockade attenuates β-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: role of MAPKs and HSPs. Apoptosis. 2015 Apr;20(4):455-65. doi: 10.1007/s10495-014-1083-z. PMID: 25544272. 3. Aira Z, Buesa I, García Del Caño G, Bilbao J, Doñate F, Zimmermann M, Azkue JJ. Transient, 5-HT2B receptor-mediated facilitation in neuropathic pain: Up-regulation of PKCγ and engagement of the NMDA receptor in dorsal horn neurons. Pain. 2013 Sep;154(9):1865-1877. doi: 10.1016/j.pain.2013.06.009. Epub 2013 Jun 12. PMID: 23769718.
In vitro protocol:
1. Seto SW, Lam HY, Lau WS, Au AL, Lam TY, Chim SS, Ngai SM, Chan SW, Leung TY, Yeung JH, Kong SK, Leung GP, Lee SM, Kwan YW. Role of monoamine oxidases in the exaggerated 5-hydroxytryptamine-induced tension development of human isolated preeclamptic umbilical artery. Eur J Pharmacol. 2009 Mar 1;605(1-3):129-37. doi: 10.1016/j.ejphar.2008.12.054. PMID: 19248248.
In vivo protocol:
1. Bharti S, Rani N, Bhatia J, Arya DS. 5-HT2B receptor blockade attenuates β-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: role of MAPKs and HSPs. Apoptosis. 2015 Apr;20(4):455-65. doi: 10.1007/s10495-014-1083-z. PMID: 25544272. 2. Aira Z, Buesa I, García Del Caño G, Bilbao J, Doñate F, Zimmermann M, Azkue JJ. Transient, 5-HT2B receptor-mediated facilitation in neuropathic pain: Up-regulation of PKCγ and engagement of the NMDA receptor in dorsal horn neurons. Pain. 2013 Sep;154(9):1865-1877. doi: 10.1016/j.pain.2013.06.009. Epub 2013 Jun 12. PMID: 23769718.
1: Bharti S, Singh R, Chauhan SS, Hussain T, Al-Attas OS, Arya DS. Phosphorylation of Akt/GSK-3β/eNOS amplifies 5-HT2B receptor blockade mediated anti-hypertrophic effect in rats. FEBS Lett. 2012 Jan 20;586(2):180-5. doi: 10.1016/j.febslet.2011.12.015. Epub 2011 Dec 26. Erratum in: FEBS Lett. 2012 Jun 21;586(13):1832. PMID: 22210189. 2: Gocht A, Distler JHW, Spriewald B, Ramsperger-Gleixner M, Weyand M, Ensminger SM, Heim C. Effects of different serotonin receptor subtype antagonists on the development of cardiac allograft vasculopathy in murine aortic allografts. Transpl Immunol. 2018 Aug;49:43-53. doi: 10.1016/j.trim.2018.04.002. Epub 2018 Apr 9. PMID: 29649585. 3: Salzer I, Gantumur E, Yousuf A, Boehm S. Control of sensory neuron excitability by serotonin involves 5HT2C receptors and Ca(2+)-activated chloride channels. Neuropharmacology. 2016 Nov;110(Pt A):277-286. doi: 10.1016/j.neuropharm.2016.08.006. Epub 2016 Aug 7. PMID: 27511837; PMCID: PMC6192515. 4: Bharti S, Rani N, Bhatia J, Arya DS. 5-HT2B receptor blockade attenuates β-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: role of MAPKs and HSPs. Apoptosis. 2015 Apr;20(4):455-65. doi: 10.1007/s10495-014-1083-z. PMID: 25544272. 5: Ozdemir E, Demirkazik A, Taskıran AS, Arslan G. Effects of 5-HT1 and 5-HT 2 Receptor Agonists on Electromagnetic Field-Induced Analgesia in Rats. Bioelectromagnetics. 2019 Jul;40(5):319-330. doi: 10.1002/bem.22196. Epub 2019 May 31. PMID: 31152464. 6: Donahue TJ, Hillhouse TM, Webster KA, Young R, De Oliveira EO, Porter JH. Examination of the mechanisms underlying the discriminative stimulus properties of the atypical antipsychotic amisulpride. Behav Pharmacol. 2024 Feb 1;35(1):47-54. doi: 10.1097/FBP.0000000000000760. Epub 2023 Nov 15. PMID: 38375659. 7: Bai CF, Liu JC, Zhao R, Cao W, Liu SB, Zhang XN, Guo HJ, Yang Q, Yi DH, Zhao MG. Role of 5-HT 2B receptors in cardiomyocyte apoptosis in noradrenaline- induced cardiomyopathy in rats. Clin Exp Pharmacol Physiol. 2010 Jul;37(7):e145-51. doi: 10.1111/j.1440-1681.2010.05388.x. Epub 2010 Mar 30. PMID: 20374255. 8: Rekik M, Lluel P, Palea S. 5-Hydroxytryptamine potentiates neurogenic contractions of rat isolated urinary bladder through both 5-HT(7) and 5-HT(2C) receptors. Eur J Pharmacol. 2011 Jan 10;650(1):403-10. doi: 10.1016/j.ejphar.2010.10.027. Epub 2010 Oct 20. PMID: 20969855. 9: Papageorgiou A, Denef C. Stimulation of growth hormone release by 5-hydroxytryptamine (5-HT) in cultured rat anterior pituitary cell aggregates: evidence for mediation by 5-HT2B, 5-HT7, 5-HT1B, and ketanserin-sensitive receptors. Endocrinology. 2007 Sep;148(9):4509-22. doi: 10.1210/en.2007-0034. Epub 2007 Jun 21. PMID: 17584957. 10: Shahi PK, Choi S, Zuo DC, Yeum CH, Yoon PJ, Lee J, Kim YD, Park CG, Kim MY, Shin HR, Oh HJ, Jun JY. 5-hydroxytryptamine generates tonic inward currents on pacemaker activity of interstitial cells of cajal from mouse small intestine. Korean J Physiol Pharmacol. 2011 Jun;15(3):129-35. doi: 10.4196/kjpp.2011.15.3.129. Epub 2011 Jun 30. PMID: 21860590; PMCID: PMC3154376. 11: Holohean AM, Hackman JC. Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones. Br J Pharmacol. 2004 Oct;143(3):351-60. doi: 10.1038/sj.bjp.0705935. Epub 2004 Aug 31. PMID: 15339859; PMCID: PMC1575347. 12: Seto SW, Lam HY, Lau WS, Au AL, Lam TY, Chim SS, Ngai SM, Chan SW, Leung TY, Yeung JH, Kong SK, Leung GP, Lee SM, Kwan YW. Role of monoamine oxidases in the exaggerated 5-hydroxytryptamine-induced tension development of human isolated preeclamptic umbilical artery. Eur J Pharmacol. 2009 Mar 1;605(1-3):129-37. doi: 10.1016/j.ejphar.2008.12.054. PMID: 19248248. 13: Aira Z, Buesa I, García Del Caño G, Bilbao J, Doñate F, Zimmermann M, Azkue JJ. Transient, 5-HT2B receptor-mediated facilitation in neuropathic pain: Up- regulation of PKCγ and engagement of the NMDA receptor in dorsal horn neurons. Pain. 2013 Sep;154(9):1865-1877. doi: 10.1016/j.pain.2013.06.009. Epub 2013 Jun 12. PMID: 23769718. 14: Filip M, Bubar MJ, Cunningham KA. Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats. Psychopharmacology (Berl). 2006 Jan;183(4):482-9. doi: 10.1007/s00213-005-0197-y. Epub 2005 Oct 28. PMID: 16261316. 15: Aira Z, Buesa I, Salgueiro M, Bilbao J, Aguilera L, Zimmermann M, Azkue JJ. Subtype-specific changes in 5-HT receptor-mediated modulation of C fibre-evoked spinal field potentials are triggered by peripheral nerve injury. Neuroscience. 2010 Jul 14;168(3):831-41. doi: 10.1016/j.neuroscience.2010.04.032. Epub 2010 Apr 20. PMID: 20412834. 16: Briejer MR, Mathis C, Schuurkes JA. 5-HT receptor types in the rat ileum longitudinal muscle: focus on 5-HT2 receptors mediating contraction. Neurogastroenterol Motil. 1997 Dec;9(4):231-7. doi: 10.1046/j.1365-2982.1997.d01-62.x. PMID: 9430791. 17: Filip M, Bubar MJ, Cunningham KA. Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther. 2004 Sep;310(3):1246-54. doi: 10.1124/jpet.104.068841. Epub 2004 May 6. PMID: 15131246. 18: Bonhaus DW, Bach C, DeSouza A, Salazar FH, Matsuoka BD, Zuppan P, Chan HW, Eglen RM. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol. 1995 Jun;115(4):622-8. doi: 10.1111/j.1476-5381.1995.tb14977.x. PMID: 7582481; PMCID: PMC1908489. 19: Delesalle C, Deprez P, Schuurkes JA, Lefebvre RA. Contractile effects of 5-hydroxytryptamine and 5-carboxamidotryptamine in the equine jejunum. Br J Pharmacol. 2006 Jan;147(1):23-35. doi: 10.1038/sj.bjp.0706431. PMID: 16230998; PMCID: PMC1615837. 20: Aira Z, Buesa I, Del Caño GG, Salgueiro M, Mendiable N, Mingo J, Aguilera L, Bilbao J, Azkue JJ. Selective impairment of spinal mu-opioid receptor mechanism by plasticity of serotonergic facilitation mediated by 5-HT2A and 5-HT2B receptors. Pain. 2012 Jul;153(7):1418-1425. doi: 10.1016/j.pain.2012.03.017. Epub 2012 Apr 19. PMID: 22520172.

View History

SB 204144

SB 204144

Lantanolic acid

Lantanolic acid

BAY1217224

BAY1217224

GK-667

GK-667

Hexbutinol

Hexbutinol

Isobioquercetin

Isobioquercetin